Go to deals
Healthcare

Sonova has had a PPA conducted for the acquisition of AudioNova

May 2017 — In September 2016, Sonova, the world’s leading provider of hearing solutions, acquired AudioNova. Subsequent to the transaction, a purchase price allocation (PPA) was conducted for accounting purposes.

Sonova, headquartered in Stäfa, Switzerland, is the leading provider of innovative hearing care solutions. The group operates through its core business brands Phonak, Unitron, Hansaton and Advanced Bionics. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants and wireless communication solutions. Founded in 1947, the group is currently present in over 100 countries across the globe and has a workforce of over 14,000 dedicated employees.

AudioNova is one of Europe’s leading hearing aid retailers and service providers. With its highly qualified staff, including 1,600 acousticians, the company assists its clients with the selection of the best hearing solution for their needs, ensuring actual use through continuous support, thus improving quality of life through better hearing. In addition to AudioNova, the group also operates under brands such as Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton and Vitakustik.

Our role in the transaction

Oaklins' team in Switzerland advised Sonova during the post-transaction phase and produced a PPA report in accordance with IFRS 3. The report contained the allocation of the consideration paid to all identifiable assets acquired and liabilities assumed.

“Oaklins' team in Switzerland supported us throughout the entire process, from the identification of the intangibles through to the auditor’s review of the PPA.”

Thomas Lenz

Senior Manager Corporate Controlling, Sonova

Talk to the deal team

Dr. Daniel Spring

Partner
Bern, Switzerland
Oaklins Switzerland

Dr. Jürg Stucker

Partner
Zurich, Switzerland
Oaklins Switzerland

Related deals

Life & Mobility has attracted investor Bolster Investment Partners
Private Equity | Healthcare

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.  

Learn more
Asana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Healthcare

Asana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital

Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.

Learn more
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Private Equity | Healthcare

Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors

Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.

Learn more